Equipment for treatment of acute respiratory failure. We developed as an EMBRAPII Unit, together with the  Braile company, equipment to assist the treatment of patients suffering from acute respiratory failure, a condition caused in severe cases of the New Coronavirus.

The treatment, called Extracorporeal Membrane Oxygenation (ECMO), is a pioneer in the country. It will support the mechanical treatment, offering the patient an “auxiliary lung”, capable of oxygenating the blood outside the body, removing carbon dioxide (CO2).

The use is indicated for adults or children, in cases of heart transplantation, myocardial infarction, cardiac arrest and acute respiratory failure, a condition also caused by the new coronavirus, in which there is inflammation of the bronchi and impairment of the alveoli, small structures that make up the respiratory system, and work by bringing oxygen into the bloodstream.

The solution aims to bring greater safety and improve medical procedures at lower costs, promoting greater access to this treatment. The National Health Surveillance Agency (Anvisa) gave the guarantee and has already approved its commercialization.